Competitor & Collaboration Analysis
Source of the list: the 20 companies SAP Ariba surfaced on BritiAI’s “Review Accounts” screen.
Important context — read first. That SAP screen is a duplicate-account check, not a competitor list. SAP matched on identity signals (name contains “AI”, registered in GBR, region, DUNS) — not on what the companies do. So the set is noisy: only a handful are genuine healthcare or public-sector AI firms; several operate in unrelated sectors, and a cluster are dormant, mis-classified, or defunct. This analysis sorts them by their actual relevance to BritiAI’s bid.
Framework context (why relevance is judged this way)
NHS SBS is establishing the Healthcare AI Solutions Framework across eight lots:
| Lot | Theme | BritiAI |
|---|---|---|
| 1 | Radiology & Diagnostic Imaging | Skip (medical-device territory) |
| 2 | Pathological Diagnosis, Early Detection & Preventative | Skip |
| 3 | Virtual & Robotic Health | Stretch |
| 4 | Predictive Analytics | Stretch |
| 5 | Research, Innovation & Development | Primary bid |
| 6 | Operational Efficiency | Primary bid |
| 7 | Advisory & Specialised Support | Primary bid |
| 8 | Combined Solutions | Automatic on ≥2 wins |
The framework places clinical-standards compliance as a minimum mandatory (clinical integrity, patient safety, NHS England + UK Government data standards) and applies significant weighting to Sustainability and Social Value. Two consequences for this analysis:
- A company operating in Lots 1–2 (imaging/diagnosis) is complementary, not competitive — it covers ground BritiAI deliberately avoids.
- A potential partner’s compliance readiness (or lack of it) is itself a collaboration lever — BritiAI’s clinical-safety/IG scaffolding is something early-stage AI firms need.
At-a-glance
| Company | What they actually do | Sector | Relevance to BritiAI |
|---|---|---|---|
| Leading AI | RAG AI assistants for UK public sector incl. cancer care, social work | Public sector / health AI | Direct competitor (+ possible partner) |
| GenScan AI | AI medical imaging — GenMRI cuts MRI scan time 20→2 min | Healthcare imaging (Lots 1–2) | Collaborator (complementary) |
| Thriving-AI | Health & social care coordination app (“care circles”) | Health/social care | Collaborator (adjacent) |
| Chartreuse AI | AI economic analysis for central/local government | Public sector AI | Adjacent (early-stage) |
| Camden AI | Data & AI consultancy (retail, media, finance) | AI consultancy | Delivery-partner bench |
| Onyx AI | Micro consultancy (finance, healthcare, tech) | Consultancy | Minor overlap |
| Stanhope AI | Brain-inspired “active inference” agentic AI; robotics/defence | Deep-tech AI | Tech-partner bench |
| Edgify | Edge / federated ML (retail self-checkout) | Retail AI | Out of scope (privacy-tech of note) |
| Versed AI | Supply-chain NLP/knowledge graph — acquired by Exiger (US) | Supply chain | Out of scope |
| KOPE AI | AI platform for offsite/modular construction | Construction | Out of scope |
| Vector AI | Freight-forwarding automation (platform “Raft”) | Logistics | Out of scope |
| Entangled AI | Applied AI for insurance, utilities, telco, manufacturing | Enterprise AI | Out of scope |
| Bionicx | AI-accelerated “insight discovery” / market research | Consulting | Out of scope |
| AI Monkeys | AI-solutions marketplace (India-owned) | Marketplace | Out of scope |
| AI Convergence Ltd | Thin UK shell (≠ Salesforce-acquired Convergence.ai) | — | Shell |
| AIS Vanguard | Construction firm, Rotherham (SAP’s misleading “best match”) | Construction | Shell / irrelevant |
| Opportuni AI | ”Tinder-for-tenders” bid-matching — in liquidation (2023) | GovTech | Defunct |
| Juvex | Companies House lists it as cosmetics retail | Retail | Shell / mis-classified |
| Synaptic AI | Micro IT consultancy, Leicester (inc. Dec 2025) | Consultancy | Shell / micro |
| AI Futures | Negligible public footprint, Hertfordshire | — | Shell / dormant |
Real companies — deep dives
Direct competitor
Leading AI Ltd — London. Builds bespoke Retrieval-Augmented-Generation (RAG) AI assistants (“KnowledgeFlow”) for UK public sector and regulated organisations, explicitly including cancer-care patients and teams, social workers (fostering/adoption), schools/colleges, and housing (repairs, tenant enquiries). This is the only genuine head-to-head with BritiAI’s Lot 6/7 territory (operational, knowledge and agentic AI inside the NHS).
- Overlap: direct, on the same buyers and use-cases.
- Differentiation for our narrative: BritiAI’s edge is the multimodal stack (ambient capture via Scribe-On-Site, agentic workflow via WardFlow, sovereign LLM training via Votee, research evidence via Beever) versus their text-RAG-assistant focus. Position on deployment depth + clinical-safety rigour + sovereign IP, not just “an assistant.”
- Action: monitor their case studies; decide competitor-vs-complement. Their RAG/knowledge layer could in principle pair with our capture/agentic layer for a Lot 8 combined story — but they are likely bidding the same framework, so treat any contact as exploratory and non-committal.
Collaboration opportunities (healthcare / public sector)
GenScan AI Ltd — London (inc. Jan 2026). Flagship GenMRI uses AI to cut MRI scan time from ~20 min to ~2 min with no hardware upgrade, lifting scanner throughput from ~20 to up to ~200 patients/day. Classified under engineering + human-health activities.
- Overlap with BritiAI: essentially none — imaging is Lots 1–2, which BritiAI deliberately skips.
- Why this is the strongest collaboration on the list: they cover the exact ground we avoid, and as a ~5-month-old company they lack the NHS route-to-market, clinical-safety/IG compliance scaffolding (DCB0129, DTAC, ISO 27001 roadmap) and trust-integration capability that BritiAI has built for this very framework. BritiAI gains diagnostic-imaging breadth for a fuller NHS story; GenScan gains a compliant deployment partner. → Outreach drafted below.
Thriving-AI Ltd — Warrington (inc. 2019). Mobile app coordinating health, social and professional care (“care circles”) for independent living.
- Overlap: low (community/social-care coordination, not acute NHS operations).
- Collaboration scope: a credible partner for a community-care / continuity-of-care angle in the Social Value narrative (which the framework weights heavily). → optional outreach below.
Chartreuse AI Ltd — London/Lambeth (inc. Apr 2025), very small. AI-powered economic analysis for central and local government (legislation-level cost/benefit, AI-safety framing).
- Relevance: public-sector AI but a different buyer and use-case (economic policy, not clinical/operational). Watch; low priority.
Bench — delivery capacity or tech depth (not competitors)
- Camden AI Ltd — established London data & AI consultancy (retail, media, finance; “AI is only as good as your data”). Useful as surge delivery / data-engineering capacity if BritiAI needs implementation hands. Not a bid rival.
- Onyx AI Ltd — 2–10-person Surrey consultancy spanning finance/healthcare/tech. Too small to compete; possible associate.
- Stanhope AI Ltd — UCL/KCL spin-out (Prof. Karl Friston, Prof. Rosalyn Moran) building active-inference / brain-inspired agentic AI; raised ~$8m (Feb 2026), aimed at robotics & defence. Not a healthcare competitor, but a high-calibre deep-tech partner if BritiAI ever needs advanced agentic IP.
- Edgify — edge & federated learning (8,000+ devices; retail self-checkout); London/US/Israel, ~$6.5m seed. Not a competitor, but their federated-learning-without-data-egress model is conceptually relevant to NHS data-sovereignty messaging.
Real, but out of scope (different sector)
- Versed AI — Cambridge supply-chain NLP/knowledge-graph, ISO 27001 certified; acquired by Exiger (US) in 2024 — no longer an independent UK player.
- KOPE AI — offsite/modular construction platform (Autodesk, Saint-Gobain investors); not healthcare.
- Vector AI — freight-forwarding automation (“Raft”), ~$15m raised; logistics.
- Entangled AI — applied AI for insurance/utilities/telco/manufacturing.
- Bionicx — Oxford “insight discovery” / AI-accelerated market research.
- AI Monkeys — AI-solutions marketplace, India-owned.
Shells & Non-Starters (disregard for competitive purposes)
- AIS Vanguard — a construction company in Rotherham (£10–25m revenue, 50–99 staff). SAP labelled it BritiAI’s “Best Match” purely on name/region; it is not an AI firm and not relevant.
- Opportuni AI — public-sector bid-matching (“Tinder-for-tenders”); liquidators appointed Aug 2023 — defunct.
- Juvex — Companies House classifies it under cosmetics retail; the “AI” association looks spurious.
- Synaptic AI — micro IT consultancy, Leicester, incorporated Dec 2025; negligible footprint.
- AI Futures — Hertfordshire; no meaningful public footprint; treat as dormant.
- AI Convergence Ltd — a thin UK shell; not the well-known Convergence.ai (a separate company acquired by Salesforce).
Recommendations
- Don’t treat this list as a competitive field. Only Leading AI is a true head-to-head competitor; everything else is complementary, out-of-sector, or inactive.
- Pursue one strong collaboration now — GenScan AI (imaging; fills the gap we deliberately avoid). Secondary, softer: Thriving-AI for the Social Value / community-care angle.
- Keep a bench for delivery surge or tech depth: Camden AI (data/delivery), Stanhope AI (agentic IP).
- In the SAP account flow: none of these is BritiAI — choose “Continue Account Creation”; do not associate with any matched account.
Suggested outreach
Primary — GenScan AI (complementary partnership; BritiAI offers compliance + NHS route-to-market)
Subject: BritiAI × GenScan — pairing your imaging AI with our NHS framework route
Hi [Founder name],
I lead delivery at BritiAI, where we’re bidding the new NHS SBS Healthcare AI Solutions Framework across the operational, research and advisory lots (5, 6 and 7). We deliberately don’t bid the imaging lots — which is exactly why GenMRI caught my eye. Cutting MRI throughput times the way you do is a genuinely compelling NHS story, and it sits in the part of the framework we leave open.
There may be a clean fit. As a prime on this framework, we’re building the parts that early-stage clinical-AI teams usually find slowest: DCB0129 clinical-safety cases, DTAC, ISO 27001 and IG scaffolding, and the trust-side deployment/advisory wrapper. If that’s useful to you, we’d be glad to share how we’re approaching it — and explore whether a referral or named-partner arrangement could give NHS buyers a fuller imaging-plus-operations picture, with the compliance evidence already in place.
No agenda beyond a 20-minute call to compare notes. Would [day/time] suit?
Best, [Name] · BritiAI · [email]
Secondary — Thriving-AI (Social Value / community-care angle)
Subject: Community-care continuity on the NHS AI framework — a quick idea
Hi [Founder name],
BritiAI is bidding the NHS SBS Healthcare AI Solutions Framework (operational and advisory lots). The framework weights Social Value heavily, and your “care circles” model for coordinating health and social care around independent living is a strong fit for the community-continuity story we want to tell credibly rather than generically.
Would you be open to a short call to explore whether there’s a referral or partner angle that helps both of us — your reach into care coordination, our route into NHS operational AI?
Best, [Name] · BritiAI · [email]
(BritiAI is the one offering the enabling layer in both cases — compliance + framework access — so each reads as “we can help you reach the NHS,” not “please help us.“)
Sources
GenScan AI — genscan.ai · Companies House · Leading AI — leadingai.co.uk · Thriving-AI — Companies House · Chartreuse AI — chartreuseanalysis.com · Camden AI — camdenai.com · Onyx AI — Companies House · Stanhope AI — stanhopeai.com · Edgify — edgify.ai · Versed AI — Exiger acquisition · KOPE — kope.ai · Vector AI — Companies House · Entangled AI — entangled.ai · AI Monkeys — Companies House · Bionicx — bionicx.ai · AIS Vanguard — Companies House · Opportuni — liquidation notice · Juvex — Companies House · Synaptic AI — Companies House · AI Futures — Companies House · Convergence.ai (Salesforce) — salesforce.com
Compiled June 2026 from public web and Companies House records. Early-stage company details change quickly — verify before acting.